Improved clinical outcomes with compliance in routine use of standard medical therapy in patients with acute coronary syndrome.

Abstract

Acute coronary syndrome is a major public health problem. It is a leading cause of morbidity and mortality in patients with cardiovascular disease. Despite multiple guidelines, the standard medical therapies are not optimally utilized for prevention of adverse events in this population. In this article, we show that, on an institutional basis, improved compliance with the use of standard preventive medical therapies can decrease adverse outcomes in this patient population. These findings can provide further impetus to practice evidence-based therapies in a cost-effective manner, which may have very important clinical, economic, and health policy implications in this current environment.